Lack of maternal milk secretion
Conditions
Interventions
Treatment group:Zengru orintment, 30g/time, three times a day
Control group:Blank control
Sponsors
First Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Puerpera who just gave birth to a baby but haven't been discharged from the hospital; 2. age from 20 to 35(not include 35); 3. gestational age from 37 weeks to 42 weeks(not include 42 weeks), give birth to the baby at the hospital, have no complications, the weight of new borned baby is greater than or equals 2500g, Apgar Score is greater than or equal 8, single birth, no diagnosing of Congenital disease or deformity; 4. agree to feed the baby by breast milk, volunteer to sign the informed consent form and agree to accomplish all the inspection, examine and intervention.
Exclusion criteria
Exclusion criteria: 1. No exhausting of air 72 hours after childbirth in puerpera underwent caesarean section; 2. puerpera who may cause new born ABO type hemolytic disease, Rh type hemolytic disease, thalassemia and favism; 3. allergic to the composition of the experimental medicine; 4. serious breast disease which causes the severe damage of brest tissue; 5. anatomical defeat and functional abnormal of the breast(such as crater nipple); 6. had augmentation mammoplasty before; 7. something that can influence the prolactin level, such as oral administration or injection of abundant estrogen, or have hyroid disease, parathyroid disease, pituitary adenoma or hyperprolactinemia; 8. patients have severe cardiovascular, liver, kidney, blood and immune system disease and patients with diabetes, mental disease, tuberculosis, or malignant tumor; 9. patient with postpartum bleeding(defined as more than 500ml of bleeding amount after childbirth); 10. patients take part in other clinical trials within 3 monthes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comprehensive efficacy assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Additive amount of new born formula;Change of EPDS from baseline;Score of breast swelling degree; | — |
Countries
China
Contacts
Public ContactLi Daocheng
Outcome results
None listed